The initial Phase 2a data build on results presented at the 2025 San Antonio Breast Cancer Symposium, demonstrating encouraging clinical activity ...
News
- Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus ...
- Popular Bay Area Barnes & Noble offers steep discounts as it prepares to close - MSN
... biotech and life science campus. ... Book with Early 2026 Deals and stay until April. Sponsored. Popular San Antonio boutique's shutdown stuns vendors ...
- Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors - BioSpace
... Bioscience, Inc., and as chief scientific officer at Zimmer, Inc. ... San Antonio, Texas. She currently serves on the board of directors of ...
- Logjam of U.S. immigration applications puts millions at greater risk of deportation | TPR
Cytotoxic T cells (blue with pink) drive · Bioscience ... A therapy that could revolutionize cancer treatment is getting a clinical trial in San Antonio.
- San Antonio mayor wants economic growth while protecting residents
San Antonio Mayor Gina Ortiz Jones ruffles feathers trying to boost the ... She wants to attract companies in artificial intelligence, biotechnology, ...